CAR- T as well as cellular genetics therapies are too costly

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing as well as innovation transmission may supply cellular genetics treatments at a cost effective expense to people all over the planet.